Phase II study of tauromustine in disseminated malignant melanoma. (Record no. 8017751)

MARC details
000 -LEADER
fixed length control field 01351 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513054745.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199408s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0959-8049
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/0959-8049(94)90448-0
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Gjedde, S B
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19940804
245 00 - TITLE STATEMENT
Title Phase II study of tauromustine in disseminated malignant melanoma.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. European journal of cancer (Oxford, England : 1990)
Date of publication, distribution, etc. 1994
300 ## - PHYSICAL DESCRIPTION
Extent 566 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Clinical Trial, Phase II; Letter
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Melanoma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nitrosourea Compounds
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Taurine
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mouridsen, H T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name L-Madsen, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jensen, N V
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Blomquist, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bergh, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Söderberg, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wählby, S
773 0# - HOST ITEM ENTRY
Title European journal of cancer (Oxford, England : 1990)
Related parts vol. 30A
-- no. 4
-- p. 566
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/0959-8049(94)90448-0">https://doi.org/10.1016/0959-8049(94)90448-0</a>
Public note Available from publisher's website

No items available.